BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33095423)

  • 21. Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
    Rinke A; Gress TM
    Digestion; 2017; 95(2):109-114. PubMed ID: 28161703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of neuroendocrine carcinoma of the anal canal with multiple bone metastases successfully treated with combined modality therapy].
    Baba H; Ishikawa T; Iwata N; Takahashi H; Masuda T; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2017-9. PubMed ID: 24393998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of Nivolumab in Large-Cell Neuroendocrine Carcinoma of the Lung - A Report of Two Cases].
    Daido W; Yamasaki M; Saito N; Ishiyama S; Deguchi N; Taniwaki M; Daga H; Ohashi N
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):59-62. PubMed ID: 28174381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature.
    Kaji K; Seishima J; Yamato M; Miyazawa M; Komura T; Marukawa Y; Ohta H; Kasashima S; Kawashima A; Yano M; Unoura M
    Clin J Gastroenterol; 2016 Feb; 9(1):43-8. PubMed ID: 26848585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rare case of primary neuroendocrine carcinoma of the central nervous system.
    Aziz Khan A; Ahuja S; Zaheer S
    Neuropathology; 2023 Oct; 43(5):421-424. PubMed ID: 37013337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 28. Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases.
    Koide N; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Miyabayashi H; Terai N; Amano J
    Surg Today; 2003; 33(4):294-8. PubMed ID: 12707827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of rectal neuroendocrine carcinoma in a patient with long-standing ulcerative colitis involving alterations of the p16-Rb pathway.
    Norose T; Ohike N; Imai H; Shibata H; Suzuki R; Isobe T; Asonuma K; Kuroki Y; Nagahama M; Tanaka JI; Takimoto M
    Pathol Int; 2017 Oct; 67(10):526-530. PubMed ID: 28851045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
    van de Pol M; Twijnstra A; ten Velde GP; Menheere PP
    J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Pure" large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature.
    Buscemi S; Orlando E; Damiano G; Portelli F; Palumbo VD; Valentino A; Marrazzo A; Buscemi G; Lo Monte AI
    Int J Surg; 2016 Apr; 28 Suppl 1():S128-32. PubMed ID: 26708705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases].
    Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
    Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
    Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine carcinoma of the extrahepatic bile duct: A case report.
    Oshiro Y; Gen R; Hashimoto S; Oda T; Sato T; Ohkohchi N
    World J Gastroenterol; 2016 Aug; 22(30):6960-4. PubMed ID: 27570432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing Cushing's syndrome: a case report.
    Yao WQ; Wu X; Li GD; Wu WL; Wang WY
    Int J Clin Exp Pathol; 2015; 8(11):15396-401. PubMed ID: 26823901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
    Ishida N; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Osawa S; Hamaya Y; Shinmura K; Sugimura H; Miura K; Furuta T; Sugimoto K
    World J Gastroenterol; 2020 Dec; 26(45):7263-7271. PubMed ID: 33362382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol.
    Bongiovanni A; Liverani C; Pusceddu S; Leo S; Di Meglio G; Tamberi S; Santini D; Gelsomino F; Pucci F; Berardi R; Lolli I; Bergamo F; Ricci S; Foca F; Severi S; Ibrahim T;
    BMJ Open; 2020 Jul; 10(7):e034393. PubMed ID: 32690499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary neuroendocrine carcinoma in oral cavity: two case reports and review of the literature.
    Wu BZ; Gao Y; Yi B
    J Oral Maxillofac Surg; 2014 Mar; 72(3):633-44. PubMed ID: 24215661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
    Suzuki H; Takayanagi S; Otake T; Ishibashi R; Osawa S; Shirai T; Takashima M; Hanai H; Kaneko E
    J Gastroenterol; 1999 Jun; 34(3):378-82. PubMed ID: 10433016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.